High prevalence of hepatitis C infection among high risk groups in Kohgiloyeh and Boyerahmad Province, Southwest Iran

Archives of Iranian Medicine

Volumn 15, Issue 5, 2012, Pages 271-274

  Sarkari, Bahador ^a   Eilami, Owrang ^b   Khosravani, Abdolmajid ^b   Sharifi, Asghar ^b   Tabatabaee, Marzieh ^b   Fararouei, Mohammad ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HCV; High risk group; Iran; Prevalence; Seroprevalence

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE PERSONNEL; HEMODIALYSIS PATIENT; HEMOPHILIA; HEPATITIS C; HIGH RISK POPULATION; HUMAN; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRESCHOOL CHILD; PRISONER; RISK ASSESSMENT; SEROPREVALENCE; SEX DIFFERENCE; THALASSEMIA; TREND STUDY; HEPACIVIRUS; PREVALENCE;

CROSS-SECTIONAL STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; IRAN; PREVALENCE;

EID: 84866504174     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999; 6: 35-47.
2. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002; 36: 21-29.
3. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: The first population-based study from Iran. Int J Infect Dis. 2010; 14: 113-116.
4. Vahdani P, Hosseini-Moghaddam SM, Family A, Moheb-Dezfouli R. Prevalence of HBV, HCV, HIV and syphilis among homeless subjects older than fifteen years in Tehran. Arch Iran Med. 2009; 12: 483-487.
5. Hosseini Asl SK, Avijgan M, Mohamadnejad M. High prevalence of HBV, HCV, and HIV infections in gypsy population residing in Shahr-E-Kord. Arch Iran Med. 2004; 7: 20-22.
6. Alavian SM, Fallahian F. Epidemiology of hepatitis C in Iran and the world. Shiraz E-Med J. 2009; 10(4): 162-172.
7. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iran Med. 2005; 8: 84-90.
8. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2010; 14: 28-33.
9. Alizadeh AHM, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan-Iran. World J Gastroenterol. 2005; 11: 4085-4089.
10. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: A case-control study. J Gastroenterol Hepatol. 2002; 17: 1092-1097.
11. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J. 2000; 6: 1114-1116.
12. Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, et al. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci. 2007; 15: 4461-4466.
13. Karimi M, Ghavanini AA. Seroprevalence of HBsAg, anti-HCV, and anti-HIV among haemophiliac patients in Shiraz, Iran. Haematologia. 2001; 31: 251-255.
14. Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J. 2007; 28: 1516-1519.
15. Mansour-Ghanaei F, Fallah MS, Shafaghi A, Yousefi-Mashhoor M, Ramezani N, Farzaneh F, et al. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Med Sci Monit. 2002; 8: 797-800.
16. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: A multicenter study. Arch Iran Med. 2006; 9: 319-323.
17. Amiri ZM, Shakib AJ, Toorchi M. Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran. East Mediterr Health J. 2005; 11: 372-376.
18. Alavian SM, Mahdavi-Mazdeh M, Bagheri-Lankarani K. Hepatitis B and C in dialysis units in Iran, changing the epidemiology. Hemodial Int. 2008; 12: 378-382.
19. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007; 18: 352-358.
20. Alavi SM, Alavi L. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006). J Infect Public Health. 2009; 2: 47-51.